ItamarMedical Ltd. announced results from a recent survey to health care professionals that covered sleep testing dynamics in their practices during 2020 and expectations for future use of Home Sleep Apnea Testing (HSAT) versus Polysomnography (PSG) testing performed in sleep laboratories. The survey, designed by Itamar Medical, was in the majority conducted by independent sleep medicine publications (Sleep Review and RT Sleep World) during February and March 2021 to determine the current dynamics of the sleep apnea diagnostic market and perceived impact of COVID-19 on traditional clinical environments. A total 213 sleep professionals participated in the survey including physicians, technicians, respiratory therapists, and sleep clinic directors and managers. Key findings of the survey included: 93% of the health care professionals surveyed currently use HSAT in their practices. HSAT represents more than 50% of the daily test volume in 66% of the practices. Compared to pre-COVID-19 test mix: Approximately 67% of respondents indicated PSG usage decreased. 32% and 35% indicated PSG usage decreased significantly and moderately, respectively. Approximately 66% of respondents indicated HSAT usage increased. 32% and 34% indicated HSAT usage increased significantly and moderately, respectively. Approximately 39% and 25% expect HSAT usage to be 50% and 75% or higher respectively of test mix post-COVID-19. Approximately 27% use only or mostly disposable HSAT. Ease of Use was noted as the most important feature for an HSAT, followed by Reliability and Accuracy.